Pharma critic Rep. Elijah Cummings is probing a dozen manufacturers over their drug pricing strategies and a bipartisan duo is calling for the FTC and Justice Department to come down on Bristol-Myers Squibb’s acquisition of Celgene.
House kicks off drug pricing, manufacturer merger oversight
